Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Deals With Huge Gantenerumab Curiosity At H1 Update

Anti-Amyloid Beta Therapy Is In Phase III For Alzheimer's

23 Jul 2021

• By Sten Stovall

Swiss Pharma Said Filing Decision Must Await GRADUATE Data Next Year • Source: Alamy

Related Content

Biogen Fires Back At Critics In Defense Of Aduhelm

22 Jul 2021

Pipeline Catalysts Key Focus For Roche’s H1 Update

15 Jul 2021

Woodcock Requests Independent Review Of Biogen-FDA Aduhelm Interaction … Not Approval Decision

10 Jul 2021

Related Companies

Roche Holding AG

Biogen, Inc.

Additional Topics

Sales & Earnings Clinical Trials Commercial Companies Research & Development Neurology Cancer BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.